Physician

Brandon M Hardesty, M.D.

According to 2025 Medicare claims, Brandon Hardesty, M.D. (NPI: 1952581027) practices internal medicine in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is INDIANA HEMOPHILIA & THROMBOSIS CENTER, INC. (NPI: 1659364800; TIN: 352047838) and primary practice location at 46260-1920. Hardesty is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Hardesty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 145 traditional Medicare patients, billed 6,523,826 HCPCS/CPT codes, and received $14,649,465 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 606 prescription claims across 90 beneficiaries totaling $189,514 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 4 records totaling $27,412. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,882,823 and ending at $14,649,465. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $272,936 and ending at $189,514. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	259	13,379	$3,882,823
2016	212	7,290	$4,210,575
2017	214	13,433	$2,856,721
2018	191	11,591	$5,396,193
2019	139	68,050	$7,372,102
2020	134	98,178	$19,796,400
2021	144	80,947	$20,571,287
2022	155	167,482	$4,444,252
2023	136	766,256	$3,469,268
2024	145	6,523,826	$14,649,465

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	643	$272,936
2016	98	440	$240,961
2017	86	518	$568,905
2018	93	625	$411,051
2019	99	570	$274,530
2020	86	465	$346,591
2021	106	503	$322,790
2022	85	332	$177,965
2023	103	346	$234,972
2024	90	606	$189,514

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	15	18	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	39	40	$55
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	23	29	$39
36415	Insertion of needle into vein for collection of blood sample	72	106	$8
93793	Anticoagulant management of patient taking warfarin	13	22	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	67	3,560	$68,377
Xarelto	Rivaroxaban	50	3,170	$59,420
Oxycontin	Oxycodone Hcl	19	266	$12,132
Enoxaparin Sodium	Enoxaparin Sodium	24	672	$6,262
Imatinib Mesylate	Imatinib Mesylate	12	354	$1,398

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$125	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$27,287	Alexion Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brandon M. Hardesty, M.D.?

Tedicare shows public-source Medicare data for Brandon M. Hardesty, M.D. (NPI 1952581027), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brandon M. Hardesty, M.D. have ACO affiliation data?

Brandon M. Hardesty, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Brandon M. Hardesty, M.D.?

Brandon M. Hardesty, M.D. is linked to INDIANA HEMOPHILIA & THROMBOSIS CENTER, INC. (billing NPI 1659364800) in the available physician profile data.

Does Brandon M. Hardesty, M.D. have Open Payments data?

Brandon M. Hardesty, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.